Neumann et al. [5] suggested that routine analysis for mutations of the RET, VHL, SDHD, and SDHB genes in patients with apparently sporadic presentation of pheochromocytoma should be considered as the clinical standard of care. The gene discussed is SDHB; the disease is hereditary pheochromocytoma-paraganglioma.